moomoo ID:NaN
Log Out
Log in to access Online Inquiry

Top Midday Gainers

MT Newswires ·  {{timeTz}}

01:38 PM EDT, 09/07/2022 (MT Newswires) -- Imara (IMRA) said it agreed to sell IMR-687, also known as tovinontrine, and all other assets related to its PDE9 program to Cardurion Pharmaceuticals.

Shares surged 64% by Wednesday afternoon as intraday trading volume soared to more than 82.8 million compared with its daily average of roughly 60,000.

Sidus Space (SIDU) said it signed a launch agreement with SpaceX for five launches of Sidus' LizzieSat satellites starting early next year.

The company expects the launches to support previously disclosed contracts with NASA and Mission Helios.

Shares jumped 27% amid an increase in intraday trading volume to over 28.2 million versus its daily average of about 6.33 million.

Glaukos (GKOS) reported topline data from two phase-3 pivotal trials of iDose TR achieved their primary efficacy endpoints through three months and demonstrated excellent tolerability and a favorable safety profile through 12 months.

Shares climbed 24% after intraday trading volume surged to over 2.58 million versus its daily average of about 457,000.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.